Related Experiment Video
Updated: Sep 21, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
LPS-induced TNF-α production is attenuated by intake with PHGG via gut microbial fermentation in mice
Yuka Inaoka Yokogawa1, Eri Oyanagi1, Takafumi Aoki2
1Department of Health and Sports Science, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Objectives:
Intake of dietary fibers promotes the production of short-chain fatty acids (SCFAs), which can affect host inflammation via gut microbial fermentation. Although partially hydrolyzed guar-gum (PHGG) is a water-soluble dietary fiber with lower viscosity, its benefits in acute inflammation are yet to be determined. The aim of this study was to investigate the effect of PHGG intake on the lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production.
Methods:
Nine-wk-old male C3 H/HeN mice were used in this study, and they were randomly divided into control diet (CD) and CD + 5% PHGG (GGCD) groups. After a dietary intervention of 6 wk, LPS (1 mg/kg) was injected into the orbital vein. Plasma TNF-α concentration and SCFAs in cecum contents were then measured. Also, the effect of gut microbiota on LPS-induced TNF-α production was evaluated in PHGG-fed mice before and after antibiotic treatment.
Results:
PHGG intake accelerated a dramatic suppression of LPS-induced TNF-α production (P < 0.01). PHGG-induced low pH in feces (P < 0.05) indicates that the gut microbiota induced high fermentation. Indeed, SCFAs in cecum contents of GGCD mice were significantly higher than in the CD group (P < 0.05). Furthermore, PHGG intake after antibiotic treatment did not induce the suppression of TNF-α.
Conclusion:
These results demonstrated that inflammation was inhibited by habitual PHGG ingestion, suggesting that this phenomenon might be associated with changes in gut microbiota-induced SCFAs production.
Insights
Partially hydrolyzed guar-gum (PHGG) intake significantly reduced tumor necrosis factor-alpha (TNF-α) production in mice. This anti-inflammatory effect is linked to increased short-chain fatty acids (SCFAs) produced by gut microbiota.
Area of Science:
- Microbiology
- Nutrition Science
- Immunology
Background:
- Dietary fibers promote short-chain fatty acids (SCFAs) production through gut microbial fermentation, influencing host inflammation.
- Partially hydrolyzed guar-gum (PHGG), a soluble fiber, has a low viscosity, but its effects on acute inflammation require further investigation.
Purpose of the Study:
- To investigate the impact of PHGG intake on lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) production.
- To explore the role of gut microbiota and SCFAs in mediating the anti-inflammatory effects of PHGG.
Main Methods:
- Male C3H/HeN mice were fed a control diet (CD) or a diet with 5% PHGG (GGCD) for 6 weeks.
- LPS was administered to induce inflammation, and plasma TNF-α levels and cecal SCFAs were measured.
- The influence of gut microbiota on LPS-induced TNF-α production was assessed before and after antibiotic treatment in PHGG-fed mice.
Main Results:
- PHGG intake significantly suppressed LPS-induced TNF-α production (P < 0.01).
- PHGG consumption led to increased SCFA levels in cecal contents (P < 0.05) and lower fecal pH, indicating enhanced microbial fermentation.
- The anti-inflammatory effect of PHGG was diminished after antibiotic treatment, highlighting the role of gut microbiota.
Conclusions:
- Habitual PHGG ingestion inhibits inflammation, likely mediated by alterations in gut microbiota and subsequent SCFA production.
- PHGG demonstrates potential as a dietary intervention for managing inflammatory conditions.
More Related Videos
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019